ARPA-H Funds 12 Teams to Build Mobile Care Platform for Rural Settings
Platform aims to create a multi-functional, rugged electric vehicle platform to deliver hospital-level care in rural communities across the country
Read More
Simplify Salon & Spa Employee Management with Meevo’s Comprehensive Software
[Sponsored] Meevo offers an all-in-one solution for managing salon and spa employees. From scheduling and time tracking to payroll and promotions, Meevo streamlines operations and supports growth. The post Simplify Salon & Spa Employee Management with Meevo’s Comprehensive Software appeared first on MedCity News.
With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen
FDA approval of Crinetics Pharmaceuticals’ Palsonify makes it the first oral first-line therapy for acromegaly, a rare endocrine disorder. The once-daily pill will compete with blockbuster acromegaly drugs from Novartis and Ipsen that are administered as injections. The post With FDA Nod in Rare Hormone Disease, Crinetics Can Challenge Blockbuster Meds From Novartis, Ipsen appeared…
Eli Lilly Commits $1B to Get Drug That Could Rival Vertex’s New Non-Opioid Pain Med
Eli Lilly’s acquisition of SiteOne Therapeutics acquisition comes ahead of Phase 2 testing of the startup’s lead drug candidate, which blocks the NaV1.8 sodium channel to treat pain. This target has clinical and regulatory validation from the recent FDA approval of Vertex Pharmaceuticals’ pain drug, Journavx. The post Eli Lilly Commits $1B to Get Drug…
Wall Street is Profiting From America’s Autism Crisis
We cannot simply accept this status quo and leave an entire generation of children unsupported when more viable options are available. The post Wall Street is Profiting From America’s Autism Crisis appeared first on MedCity News.
Axsome Aims for FDA Filing in Alzheimer’s Agitation Despite Mixed Bag of Phase 3 Data
One Phase 3 test of Auvelity met its main goal in Alzheimer’s agitation while the drug’s other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimer’s agitation drug. The post Axsome Aims…
Stakeholders Describe Progress With 360X Referral Management
The 360X standards are designed to improve referral management, close communication gaps and enable transparency between care settings
Navina Snags $55M for Its Value-Based Care AI Copilot
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models. The post Navina Snags $55M for Its Value-Based Care AI Copilot appeared first on MedCity News.
Increasing Efficiency and Reimbursements with Clearinghouses
Clearinghouses are just one great example of how the enhanced exchange of healthcare data can increase efficiency for healthcare providers and the greater healthcare community. The post Increasing Efficiency and Reimbursements with Clearinghouses appeared first on MedCity News.
As a Diversity Grant Dies, Young Scientists Fear It Will Haunt Their Careers
Adelaide Tovar, a University of Michigan scientist who researches genes related to diabetes, used to feel like an impostor in a laboratory. Tovar, 32, grew up poor and was the first in her family to graduate from high school. During her first year in college, she realized she didn’t know how to study. But after…